CRPS Expert Witness Guide: How Pain Management Experts Evaluate Complex Regional Pain Syndrome Cases

What Is CRPS?

Complex Regional Pain Syndrome is a chronic pain condition involving dysfunction of the somatosensory nervous system and autonomic nervous system, typically affecting one limb following a precipitating event — trauma, surgery, nerve injury, or in some cases a purely medical trigger such as myocardial infarction or stroke. Its defining clinical characteristic is pain that is disproportionate to the precipitating event in intensity, duration, or both, accompanied by sensory abnormalities, autonomic dysregulation, and frequently motor and trophic changes affecting the involved limb.

CRPS was historically described by a variety of overlapping terms — Reflex Sympathetic Dystrophy (RSD), causalgia, Sudeck's atrophy, algodystrophy, and shoulder-hand syndrome — reflecting both the diversity of its clinical presentations and the incomplete understanding of its underlying pathophysiology during much of the 20th century. The International Association for the Study of Pain (IASP) diagnostic criteria adopted in 1994 introduced greater diagnostic consistency, and the Budapest Criteria — established at a 2003 consensus conference and subsequently validated in prospective studies — replaced the earlier IASP criteria as the current international diagnostic standard.

CRPS pathophysiology involves multiple interacting mechanisms. Peripheral sensitization at the site of injury drives ongoing nociceptive input. Central sensitization in the dorsal horn and supraspinal pain-processing regions amplifies that input and generates the disproportionate pain response that characterizes the condition. Autonomic dysregulation — mediated through the sympathetic nervous system — produces the vasomotor, sudomotor, and trophic changes that distinguish CRPS from other chronic pain conditions. And neuroinflammatory mechanisms, including cytokine dysregulation and neurogenic inflammation at the affected limb, contribute to the edema, skin temperature changes, and skin color changes that are among the most objectively measurable clinical features of the condition. For the clinical expertise framework applicable to CRPS litigation, see the CRPS expertise page.

CRPS Type I vs. Type II

CRPS is classified into two types based on the presence or absence of a confirmed peripheral nerve injury at the precipitating event. CRPS Type I occurs without a confirmed peripheral nerve injury — previously called Reflex Sympathetic Dystrophy or RSD. The precipitating event produces the CRPS syndrome despite the absence of an identifiable nerve lesion. CRPS Type II occurs in the setting of a confirmed peripheral nerve injury — historically called causalgia — identifiable through history, physical examination, electrodiagnostic testing, or imaging.

Both types produce clinically identical presentations and are diagnosed using the same Budapest Criteria. The distinction matters in litigation primarily in the following ways. In Type I cases, the causation analysis must address why an injury without confirmed large-fiber nerve damage produced a CRPS-consistent pathophysiology — the mechanism discussion is the same one, but the absence of an electrodiagnostically confirmed nerve injury means the causation framework must engage small-fiber dysfunction, central sensitization, and neuroinflammatory mechanisms more explicitly. In Type II cases, the nerve injury itself must be characterized and its causal relationship to the precipitating event established, before the connection between the nerve injury and the subsequent CRPS syndrome is addressed as a second analytical step.

From a damages standpoint, Type I and Type II CRPS are equivalent — both conditions are treated by the same clinical framework, carry the same range of future care needs, and involve the same SCS candidacy pathway when refractory. The litigation strategy difference is in how the causation and diagnostic opinions are structured, not in the damages framework.

The Budapest Criteria

The Budapest Criteria are the current international standard for CRPS diagnosis and the foundation of virtually every clinical opinion in CRPS litigation. Understanding their structure — and the specific ways a treating record can satisfy or fail to satisfy them — is the single most important analytical skill in CRPS expert witness evaluation.

The Budapest Criteria for clinical diagnosis require four elements to be present: (1) continuing pain disproportionate to any inciting event; (2) the patient reports at least one symptom in three or more of four categories: sensory (hyperesthesia or allodynia), vasomotor (temperature asymmetry or skin color changes or skin color asymmetry), sudomotor or edema (sweating changes or sweating asymmetry or edema), and motor or trophic (decreased range of motion, weakness, tremor, dystonia, or trophic changes affecting hair, nails, or skin); (3) at the time of evaluation, the clinician documents at least one sign in two or more of those categories on physical examination — meaning a finding the clinician directly observes or measures, not merely a symptom the patient reports; and (4) no other diagnosis better explains the signs and symptoms.

The distinction between symptoms — what the patient reports — and signs — what the clinician documents at examination — is the single most consequential documentation distinction in CRPS litigation. A treating record that contains a CRPS diagnosis with extensive patient symptom narrative but sparse or absent clinician-recorded examination findings — no documented temperature asymmetry measurements, no recorded skin color comparison, no recorded edema grading, no recorded motor assessment — satisfies the symptom reporting requirement but not the sign documentation requirement. Defense experts exploit this gap systematically and effectively.

For research purposes, the Budapest Criteria are marginally more stringent than the clinical criteria: the research version requires signs in at least three of four categories rather than two. This distinction is clinically relevant because some physicians document the diagnosis using research criteria without stating which version they are applying, creating ambiguity in the treating record that a careful reading of the examination notes — rather than the diagnostic impression alone — must resolve.

Sensory Findings: Allodynia and Hyperalgesia

Sensory abnormalities — specifically allodynia and hyperalgesia — are among the most consistently documented and most clinically distinctive features of CRPS. Allodynia is pain produced by a stimulus that would not normally produce pain: the light brush of clothing against the skin, air movement across the affected extremity, or gentle palpation of an area with calibrated monofilaments. Hyperalgesia is an exaggerated pain response to a stimulus that would normally produce pain: greater-than-expected pain from light pinprick, from temperature application, or from pressure applied to the affected region.

In CRPS litigation, the documentation standard for sensory findings requires that the clinician record the examination method — not merely the conclusion. A treating note that states "allodynia present" without identifying the stimulus used, the distribution of the allodynia, and how the response compared to the contralateral limb or to a normal response threshold provides less litigation-durable documentation than one that records, for example, "light touch allodynia extending from the dorsum of the right foot to mid-calf, confirmed with 0.07 g von Frey filament — absent on the contralateral limb." The specificity of the examination record determines how reliably a plaintiff expert can defend the sensory finding category against a defense challenge.

Vasomotor, Sudomotor, and Trophic Changes

The vasomotor, sudomotor, and trophic findings in CRPS are, in one important respect, more objectively documentable than the sensory findings — because they represent clinician-observable physical findings rather than patient-reported sensory experiences. A clinician who measures and records limb temperature asymmetry with an infrared thermometer, who photographs and documents skin color asymmetry, who measures and records edema with a tape measure at a defined point on the limb, or who documents sweating asymmetry through comparison of skin moisture at symmetric sites, generates a treating record that is substantially harder to challenge than one that records these findings in subjective or uncalibrated terms.

Vasomotor findings include skin temperature asymmetry between the affected and unaffected limbs, and skin color changes ranging from mottled or dusky discoloration to erythema or pallor. These findings fluctuate over time and across disease stages — early CRPS often presents with a warm, red, edematous limb, while chronic CRPS more often presents with a cool, cyanotic, atrophic limb. This stage-related variability means that a single examination documenting the absence of temperature asymmetry does not exclude the diagnosis — but it does mean that the clinical evolution of these findings over the treating record must be traced rather than assumed.

Sudomotor and edema findings include sweating changes — hyperhidrosis (increased sweating) or hypohidrosis (decreased sweating) in the affected distribution — and edema, which may be diffuse or pitting and typically involves the distal extremity. Both findings are most effectively documented with objective measurement: sudomotor testing with a resting sweat output device or quantitative sudomotor axon reflex test (QSART) in centers with access to those methods, or, in more typical clinical practice, by direct clinician comparison of sweating between symmetric sites and by tape-measure edema documentation.

Motor and trophic findings encompass a range of clinically distinct observations: decreased range of motion at the affected joint or joints, weakness in the distribution of the affected extremity, tremor, dystonia, and trophic changes affecting the skin (thinning, shiny skin, subcutaneous atrophy), hair (increased or decreased growth, loss), and nails (brittleness, ridging, abnormal growth rate). Trophic changes in particular often develop over the course of months and are among the most objectively visible findings in chronic CRPS — they are difficult to dispute when photographically documented in the treating record but become a credibility issue when the record relies solely on verbal description without objective measurements or photographs.

Motor Findings and Functional Impairment

Motor dysfunction in CRPS is distinct from the motor deficits seen in peripheral nerve injury or central nervous system disease. CRPS motor changes are characterized by weakness and limited range of motion disproportionate to visible atrophy, tremor of variable frequency and amplitude, and in some cases dystonia — involuntary sustained muscle contraction that may produce fixed posturing of the affected limb. The functional consequences of these motor changes, combined with the sensory hyperalgesia that makes ordinary movement painful and the autonomic changes that impair normal limb use, produce functional impairment that can be severe and can be objectively documented through functional capacity evaluation, gait analysis, and structured physical examination of grip strength, pinch strength, and range of motion with recording of end-range behavior.

For litigation purposes, functional impairment documentation is important at two levels. First, it provides objective evidence of the real-world consequence of the CRPS condition, relevant to both damages and to future rehabilitation needs. Second, it provides an objective basis for the treating clinician's Budapest Criteria motor/trophic category documentation — a clinician who records specific grip strength measurements, specific range of motion measurements, and specific tremor observations satisfies the motor sign documentation requirement; one who records only a general statement of "functional impairment" does not.

Diagnostic Challenges and Differential Diagnosis

CRPS presents several diagnostic challenges that defense experts routinely use to contest the diagnosis in litigation. Understanding each challenge from the physician's perspective helps attorneys evaluate whether a given defense opinion rests on sound clinical analysis or on a misapplication of diagnostic criteria.

The differential diagnosis for CRPS includes conditions that can produce overlapping clinical features: peripheral neuropathy (including small-fiber neuropathy, which shares allodynia and autonomic features); thoracic outlet syndrome; vascular occlusive disease producing limb temperature and color changes; inflammatory arthritis producing joint swelling and warmth; and, in cases involving the upper extremity, cervical radiculopathy producing both sensory symptoms and autonomic-appearing changes. Each of these conditions is distinguishable from CRPS by clinical examination, appropriate diagnostic testing, or the characteristic distribution of findings. A defense expert who argues that one of these alternative diagnoses explains the plaintiff's clinical picture must do so with reference to findings that affirmatively support the alternative diagnosis — not merely by pointing to the existence of an alternative on the differential.

The factitious disorder argument — the suggestion that the plaintiff's clinical presentation is consciously or unconsciously produced rather than physiologically based — is raised occasionally in CRPS litigation and requires careful handling by the treating team and the plaintiff expert. Physical examination findings such as measured temperature asymmetry, objectively documented edema, and verifiable trophic skin and nail changes cannot be voluntarily produced by the patient and are the appropriate focus of a rebuttal opinion when factitious or non-organic overlay arguments are raised. Sensory testing with standardized instruments, and documentation of findings consistent across multiple examiners over time, provides the most durable clinical foundation for rebuttal.

The malingering or symptom amplification argument presents a structurally different challenge: it does not dispute the existence of the underlying condition but argues that the reported severity is exaggerated. In CRPS, the pain experience is inherently subjective and subject to amplification at the central level — the condition itself involves central sensitization, meaning that supraspinal pain amplification is part of the pathophysiology rather than a sign of voluntary exaggeration. A well-framed plaintiff expert opinion distinguishes between the objective examination findings establishing the diagnosis and the subjective pain severity reporting, acknowledges the role of central sensitization in amplifying pain experience, and avoids framing the defense symptom argument as a direct challenge to the objective examination findings that actually establish the Budapest Criteria.

CRPS Causation Analysis

CRPS causation analysis is structured as a two-part inquiry — and both parts must be addressed to produce a durable opinion. The first question is whether the Budapest Criteria diagnosis is established by the treating record. The second question is whether the precipitating mechanism is clinically sufficient to produce CRPS, and whether the temporal relationship between the mechanism and the documented onset of CRPS findings is consistent with a causal connection. Defense experts in CRPS litigation challenge each question independently, which means a plaintiff opinion that addresses only one while assuming the other leaves an exposed flank.

Causation analysis in CRPS proceeds through the same clinical layers applicable to any pain management causation opinion — mechanism, pre-existing baseline, temporal relationship, objective findings, aggravation analysis, alternative explanations, treatment chain, and applicable causation standard. For a detailed framework applicable across causation disputes, see the article on how pain management experts evaluate causation.

Trauma-Related CRPS

Trauma-related CRPS — arising from fractures, dislocations, crush injuries, contusions, sprains, and lacerations — accounts for the majority of CRPS cases encountered in personal injury litigation. The causal connection between trauma and CRPS requires the expert to address three clinical questions: whether the trauma was of a type documented in the published literature to precipitate CRPS, whether the temporal development of Budapest Criteria findings following the trauma is consistent with the known onset pattern of post-traumatic CRPS, and whether the pre-accident clinical record establishes a baseline free of CRPS-consistent signs and symptoms in the affected limb.

A critical aspect of trauma-related CRPS causation is the inadequacy of mechanism severity as a disqualifying argument. Defense experts routinely argue that the trauma was too mild to cause CRPS — a conclusion the published literature does not support as a general proposition. What the literature documents is a range of mechanisms capable of precipitating CRPS, including wrist sprains, ankle sprains, minor fractures, venipuncture, and prolonged immobilization, with no established minimum severity threshold. The expert addressing this argument should cite the published case series and epidemiological literature on CRPS-precipitating mechanisms, rather than accepting the premise that mechanism severity predicts CRPS likelihood.

Surgery-Related CRPS

Post-surgical CRPS is a recognized complication of orthopedic and other surgical procedures — particularly those involving the extremities — and arises in both personal injury and medical malpractice contexts. In personal injury cases, the causal chain typically runs from the accident to a surgical intervention necessitated by the accident to post-surgical CRPS, requiring the expert to address each link: accident to surgical indication, surgical intervention to CRPS onset, and the timing of each step relative to the documented clinical findings.

In medical malpractice cases, the CRPS itself may be the basis of the malpractice claim — either because the surgery was performed without adequate indication (a standard of care question) or because the post-surgical CRPS was not recognized and treated with appropriate timeliness, resulting in a progression to a chronic refractory stage that might have been avoided with earlier intervention. Standard of care analysis in delayed CRPS diagnosis malpractice cases requires the expert to address: what clinical findings were documented at the post-operative visits, whether those findings were consistent with early CRPS, what the standard of care required in terms of CRPS recognition and referral at those findings, and whether earlier diagnosis and treatment would have been likely to alter the plaintiff's outcome. For standard of care analysis applicable to CRPS malpractice cases, contact the office directly.

Delayed Diagnosis and Evolving Presentation

Delayed CRPS diagnosis is a recurring clinical and litigation issue because the condition typically evolves over weeks to months following the precipitating event, and the full Budapest Criteria picture often does not emerge immediately after the triggering trauma or surgery. Early CRPS may present with pain disproportionate to the injury and early sensory changes — but the objective autonomic and trophic findings that contribute to the Budapest Criteria sign documentation may not be prominent or measurable in the immediate post-injury period.

For litigation, delayed diagnosis creates a specific gap in the treating record: the plaintiff may have been assessed repeatedly in the weeks following the injury without a CRPS diagnosis being made, and only later — once the full clinical picture became apparent — received a formal diagnosis. Defense experts use this gap to argue that the condition did not develop at the time of the injury, or that the delayed diagnosis reflects the absence of clinical findings rather than their under-recognition. A plaintiff expert addressing delayed diagnosis must trace the clinical evolution through the treating record — identifying the earliest documented clinical findings consistent with emerging CRPS, explaining why those findings are consistent with CRPS pathophysiology even in the absence of a contemporaneous diagnosis, and establishing that the temporal pattern is consistent with what the published literature describes for the typical onset and evolution of post-traumatic CRPS.

Medical Necessity Disputes

Medical necessity disputes in CRPS litigation arise most frequently in two contexts: disputes over past treatment actually rendered, and disputes over projected future treatment in damages analysis. In both contexts, the clinical foundation for the necessity opinion is the same — the treating record documenting the indication, the treatment rendered, and the clinical response.

For interventional procedures in CRPS — sympathetic blocks, SCS trial and permanent implantation, and peripheral nerve stimulation for refractory cases — the necessity analysis requires documenting the clinical indication, the conservative treatment pathway exhausted before escalation, and the documented response to each treatment tier before advancement to the next. For pharmacological management — neuropathic agents (gabapentin, pregabalin, tricyclic antidepressants, SNRIs), topical treatments (lidocaine patches, capsaicin), and where supported by the clinical record, opioid analgesics for chronic refractory CRPS — the necessity analysis addresses the indication, the dose titration and response documentation, and the absence of safer alternatives producing adequate relief.

A point that experienced CRPS examiners recognize but that is less obvious to non-specialist reviewers: the pain management medical necessity review for CRPS treatment must account for the condition's temporal complexity. A treatment that appears aggressive when evaluated in isolation from the clinical timeline may be entirely appropriate when placed in the context of an established refractory CRPS course with documented failure of multiple prior treatment modalities. The chronological structure of the treating record — when each modality was tried, what response was documented, why escalation was clinically supported — is the foundation of a defensible necessity opinion. For a clinical framework applicable across necessity disputes, see the article on how pain management experts evaluate medical necessity.

Spinal Cord Stimulation in CRPS

Spinal cord stimulation occupies a unique position among CRPS treatments: it is one of the few interventions for severe chronic pain supported by multiple randomized controlled trials, with evidence specific to the CRPS population. RCT evidence from published trials — including landmark studies published in peer-reviewed pain medicine journals — demonstrates significant, sustained pain reduction from SCS compared to physical therapy alone in CRPS patients meeting the study criteria. SCS for CRPS carries a Category I recommendation in published neuromodulation society guidelines, which is important for litigation because it means a future care projection or a past treatment necessity opinion that includes SCS is grounded in a higher tier of clinical evidence than most other CRPS interventions.

The SCS necessity analysis in a CRPS case requires the same pre-implant documentation framework applicable to any SCS case: a recognized indication — CRPS is a primary listed indication for SCS in virtually all published guidelines — documented failure of conservative and interventional management, a pre-implant psychological evaluation using validated instruments, and a successful SCS trial period documenting at least 50% pain reduction from a recorded pre-trial baseline. The documentation specificity for each of these elements determines how well the necessity opinion withstands defense challenge at deposition and trial. For a detailed analysis of SCS necessity evaluation applicable to CRPS cases, see the article on SCS medical necessity evaluation and the spinal cord stimulation expertise page.

In CRPS future care projections, SCS generates a substantial cost component when projected over the plaintiff's life expectancy: device implantation, periodic battery replacement (or rechargeable system management costs), programming visits at published frequency intervals, revision probability grounded in published device outcome data, and lead revision or explantation if required. Each of these components requires its own clinical rationale grounded in the plaintiff's specific clinical picture and published device outcome literature — not a generic template.

Sympathetic Blocks and Interventional Management

Sympathetic nerve blocks are a standard component of the CRPS interventional management pathway. Stellate ganglion blocks address sympathetically maintained pain in upper extremity CRPS; lumbar sympathetic blocks address lower extremity CRPS. A series of sympathetic blocks — typically three to five at defined intervals — is usually attempted as part of the escalation pathway before SCS consideration. The clinical rationale is that a subset of CRPS patients have a significant sympathetically maintained pain component that responds to sympatholytic intervention, and identifying those patients and providing a treatment trial is both clinically appropriate and necessary to document prior to escalation.

In litigation, the sympathetic block response serves multiple functions. Diagnostically, a documented positive response to a sympathetic block — meaning objective, contemporaneously recorded pain reduction in the blocked distribution — is additional clinical evidence of the CRPS mechanism, particularly the sympathetically maintained pain component. From a necessity standpoint, the documentation of a sympathetic block trial and its outcome is part of the escalation evidence chain that supports SCS necessity when the block series provides inadequate or insufficiently durable relief. A treating record that proceeds directly to SCS without a sympathetic block trial — in a patient where the clinical presentation would have supported such a trial — is more vulnerable to a defense necessity challenge than one that shows a documented sympathetic block trial with partial or insufficient response serving as the clinical basis for SCS escalation.

Other interventional approaches used in CRPS management that may appear in litigation records include intravenous regional blocks (Bier blocks with guanethidine or lidocaine), spinal cord stimulation, and — for patients with a significant peripheral afferent contribution — peripheral nerve stimulation. The peripheral nerve stimulation pathway in CRPS is an emerging option with a developing evidence base; its inclusion in a future care projection requires clinical documentation that the plaintiff's specific CRPS presentation includes a peripheral afferent component reasonably addressed by PNS rather than SCS.

Physical Therapy and Functional Restoration

Physical therapy and occupational therapy are a cornerstone of CRPS management, with published evidence supporting desensitization protocols, graded motor imagery, mirror therapy, and graded exposure to movement as components of CRPS rehabilitation. Physical therapy in CRPS is distinctively different from the rehabilitation approach used for musculoskeletal injuries: the allodynia, hyperalgesia, and movement-provoked pain in CRPS mean that standard progressive exercise protocols must be modified to avoid the paradoxical pain exacerbation that can follow inappropriate early aggressive mobilization.

For litigation purposes, physical therapy documentation in CRPS cases is relevant at two levels. First, it documents the rehabilitation treatment effort — which supports future care projections for ongoing or episodic therapy need. Second, it provides an independent clinical record of functional status and functional change over time, which is relevant to damages and to the credibility of the CRPS diagnosis: a physical therapist's serial records documenting consistent allodynia responses, limited range of motion, and functional limitations corresponding to the treating physician's examination findings strengthen the treating record's overall diagnostic documentation.

Ketamine and Emerging Therapies

Ketamine infusion therapy has an evidence base in refractory CRPS — with published studies demonstrating meaningful pain reduction in CRPS patients unresponsive to conventional management — and appears in the treatment records of some CRPS plaintiffs whose cases have advanced to the point of seeking experimental or emerging options. Ketamine is not a first-line or standard-of-care treatment for CRPS, and its inclusion in a future care projection requires specific clinical justification: documentation that the plaintiff has failed the conventional CRPS treatment pathway, clinical evidence that the plaintiff is a ketamine candidate, and citation to published evidence supporting ketamine in the CRPS population with specific reference to dosing protocols and response documentation.

Attorneys whose CRPS cases include ketamine infusion records should ensure that the pain management expert addresses ketamine specifically — both as a past treatment whose necessity may be in dispute and, if included in a future care projection, as a component requiring its own evidence-based clinical rationale. An expert who includes a lifetime projection of ketamine infusions without addressing the evidence base for ketamine in CRPS and the plaintiff's specific clinical candidacy is producing a future care opinion vulnerable to a Daubert or Sargon-type reliability challenge.

Other emerging treatments that occasionally appear in CRPS litigation records include low-dose naltrexone and intravenous immunoglobulin (IVIG). Both have very limited evidence bases in CRPS; their inclusion in any future care projection requires explicit, specific justification from published literature and from the plaintiff's individual clinical record.

Psychological Factors in CRPS Litigation

Psychological factors in CRPS litigation must be understood at two levels that are often conflated but are clinically and legally distinct. The first is the bidirectional relationship between CRPS and psychological function: chronic, severe, and often poorly understood pain of the severity seen in CRPS produces depression, anxiety, post-traumatic stress, and sleep dysfunction, and these sequelae are part of the compensable clinical burden attributable to the CRPS condition, not evidence against its legitimacy. The second is the question of whether pre-existing psychological conditions produced or amplified the plaintiff's reported symptoms — a defense argument that requires careful parsing because it applies only to subjective symptom reporting, not to the objective examination signs that form the diagnostic core of the Budapest Criteria.

Pre-implant psychological evaluation is required in the SCS decision pathway for CRPS and is specifically relevant to litigation because defense experts in SCS necessity cases routinely challenge the adequacy of the psychological clearance. A psychological evaluation for CRPS-SCS candidacy must use validated instruments — depression, anxiety, and somatization scales with published normative data — and must be performed by a licensed psychologist or equivalent clinician with experience in chronic pain psychology, not simply noted as "cleared for SCS" without documented instrument use and scoring. The adequacy of this documentation is a recurring defense target in California and Texas SCS litigation specifically, as discussed in the California guide and the Texas guide.

Future Medical Care Projections in CRPS

Future medical care projections in CRPS are frequently the largest single damages component in high-value cases, given that CRPS in its refractory form requires multi-modal management across decades — interventional procedures, pharmacological management, rehabilitation, psychological support, and in many cases SCS with its associated device replacement and programming costs. The projection must be built component by component, with each cost category carrying its own clinical foundation tied to the plaintiff's documented condition, documented treatment response, and the published literature on expected treatment course for the plaintiff's diagnostic profile.

The life expectancy multiplier applies to a treatment burden that is inherently expensive per year of care, which means that even modest differences in the projected future care cost per year produce very large differences in the total damages calculation over a plaintiff's remaining life expectancy. This economic reality puts particular scrutiny on the clinical precision of the future care opinion — an opinion that can be challenged as overstating the annual treatment burden by 20% results in a much larger absolute damages reduction when multiplied by a 40-year life expectancy than the same percentage dispute in a case with a lower per-year treatment cost. Attorneys building a CRPS future care case should invest in the clinical precision of the underlying pain management opinion, because that precision — or its absence — determines how much of the future care calculation survives defense cross-examination. For a detailed overview of the future medical care review services available for CRPS cases, contact the office directly.

Independent Medical Evaluations in CRPS Cases

IMEs in CRPS cases are more consequential — and more technically demanding — than IMEs in most other pain management case types, for a specific reason: the Budapest Criteria require clinician-documented examination signs, which means that an IME performed by a defense expert provides a contemporaneous clinical examination record that may confirm, qualify, or contradict the Budapest Criteria findings documented by the treating physician. An IME in which the defense expert documents the absence of objective Budapest Criteria signs — no measured temperature asymmetry, no observed skin color asymmetry, no documented edema, no trophic changes — is more powerful than a defense records review opinion, because the IME adds contemporaneous clinical examination findings that the defense expert can use to dispute the diagnosis at the sign documentation level rather than only at the records interpretation level.

Plaintiff counsel should prepare CRPS clients carefully for defense IMEs. The allodynia and examination-provoked pain responses in CRPS are real and should be documented by the plaintiff's account of the examination — what stimuli produced what responses, what the examiner documented versus what the plaintiff experienced — because discrepancies between the defense IME findings and the treating record are the foundation of many defense expert opinions in CRPS cases. Retaining a plaintiff-side pain management expert to provide a rebuttal opinion specifically addressing the defense IME's examination methodology and findings is a critical step in cases where the defense IME disputes the Budapest Criteria sign documentation. For a detailed overview of the IME services available for CRPS cases, contact the office directly.

Defense Arguments

Defense experts and defense counsel in CRPS litigation consistently advance a defined set of arguments across jurisdictions. Attorneys should anticipate these and confirm that the plaintiff expert's opinion addresses each:

• Insufficient Budapest Criteria documentation: The treating record contains a CRPS diagnosis label without contemporaneous, clinician-recorded examination findings in the required sign categories — the record shows what the patient reported but not what the clinician observed and measured. This is the most frequently successful defense argument and the one that requires the most specific response from the plaintiff expert.
• Mechanism insufficiency: The precipitating injury was too minor to cause CRPS. This argument is inconsistent with the published CRPS literature but is raised routinely and requires a specific literature-grounded rebuttal addressing the range of documented precipitating mechanisms.
• Normal imaging disproves the diagnosis: A defense argument that misapplies the diagnostic standard — CRPS is a clinical diagnosis that does not require structural imaging abnormality, and the absence of MRI pathology is neither required nor inconsistent with the diagnosis.
• Normal EMG excludes CRPS: A defense argument that misunderstands the distinction between large-fiber peripheral neuropathy (what EMG evaluates) and the small-fiber dysfunction and central sensitization that characterize CRPS. A normal EMG is consistent with CRPS Type I by definition.
• Alternative diagnosis: A competing diagnosis — peripheral neuropathy, small-fiber neuropathy, conversion disorder, factitious disorder — better explains the clinical picture. Requires affirmative clinical support for the alternative, not merely its existence on a differential.
• Condition will resolve or has resolved: Future care projections overstate likely treatment need because CRPS resolves in a significant proportion of patients. Requires addressing the plaintiff's specific prognostic profile — disease duration, treatment response, clinical trajectory — against published outcome predictors.

Plaintiff Arguments

Plaintiff experts and plaintiff counsel in CRPS cases can advance the following arguments when the treating record supports them:

• Budapest Criteria systematically documented: When the treating record contains serial examination findings documenting each Budapest Criteria category with the specificity required — measured temperature asymmetry, photographed skin changes, graded edema, structured motor assessment — the plaintiff expert can affirmatively demonstrate criteria satisfaction rather than merely defending against a documentation challenge.
• Clinical evolution consistent with published CRPS trajectory: The temporal progression of findings from early sensory and vasomotor changes to later trophic and motor changes, documented in the treating record over time, matches the published description of CRPS natural history — strengthening causation and diagnosis simultaneously.
• Eggshell susceptibility and mechanism range: A plaintiff who develops CRPS after minor trauma is not presenting an implausible medical history — the published literature documents CRPS after equally minor mechanisms, and the plaintiff's biological susceptibility to CRPS following the trauma at issue does not diminish the defendant's legal responsibility for that outcome.
• Evidence-based treatment trajectory: Each step of the treatment chain — from conservative care to interventional procedures to SCS — is supported by published guidelines and by the documented failure of prior treatment modalities at each step, producing a necessity foundation that is difficult to challenge when the record is complete.
• Permanence supported by prognostic profile: Where the plaintiff's clinical trajectory, disease duration, treatment-refractory course, and documented psychological and functional sequelae are consistent with the published prognostic factors associated with chronic refractory CRPS, the future care projection for long-term or indefinite management is grounded in the patient's own clinical profile rather than in generic assertions.

Common Mistakes Attorneys Make in CRPS Cases

From the perspective of a physician who regularly evaluates CRPS clinical records and provides expert opinions in CRPS litigation, the following errors recur with enough frequency that addressing them specifically is the most practical contribution this guide can make for attorneys encountering CRPS cases for the first time or in a new jurisdiction:

• Relying on MRI findings — or their absence — as diagnostic evidence: Attorneys sometimes evaluate the strength of a CRPS case based on whether imaging shows "something." CRPS is a clinical diagnosis. Normal MRI is entirely consistent with CRPS. Abnormal MRI may show findings relevant to the precipitating injury but does not establish or exclude CRPS. The Budapest Criteria — and the treating record's documentation of them — are the diagnostic foundation, not the imaging.
• Misunderstanding what the Budapest Criteria actually require at the sign level: The most damaging documentation gap in CRPS cases is the distinction between symptoms (what the patient reports) and signs (what the clinician observes and measures). An attorney who reads a treating record and concludes that CRPS is well-documented because the notes contain extensive patient symptom narrative may be overlooking the absence of clinician-recorded examination signs — the element that defense experts will attack. The plaintiff expert should be asked specifically whether the treating record documents clinician-observed signs, not just patient-reported symptoms, in at least two Budapest Criteria categories at examination.
• Assuming a normal EMG rules out CRPS: Defense experts raise this argument routinely. It is clinically incorrect for CRPS Type I, and it is worth understanding why before the deposition — a basic understanding of the distinction between large-fiber (EMG-visible) and small-fiber/central (CRPS-relevant, EMG-invisible) dysfunction allows the attorney to challenge this argument more effectively at deposition and in briefing.
• Failing to document clinical progression through time: CRPS findings change over the clinical course. A treating record that captures the initial post-injury presentation but lacks serial examination findings at subsequent visits — leaving gaps of months without documented Budapest Criteria findings — provides a weaker clinical foundation than one that shows a consistent and evolving clinical picture. Plaintiff attorneys should review the treating record's serial completeness, not just the initial and most recent visits, before evaluating the case.
• Confusing pain severity with objective clinical findings: A plaintiff who reports severe pain in compelling terms has not, by that fact alone, established a clinically documented CRPS case. Conversely, a plaintiff who is stoic or minimizing in describing their experience has not undermined a well-documented Budapest Criteria record. The clinical strength of a CRPS case rests on examination findings, not on the intensity of the plaintiff's pain narrative.
• Overlooking the pre-implant psychological evaluation requirement for SCS: When SCS is a component of past treatment or a projected future care item, attorneys should confirm that the treating record contains a pre-implant psychological evaluation using validated instruments — not merely a note that the patient was "cleared." The adequacy of that documentation is a routine defense target, and its absence or inadequacy is one of the most frequently successful SCS necessity challenges.
• Retaining an expert who addresses only one dimension of the dual-track analytical requirement: A CRPS opinion that addresses the Budapest Criteria documentation thoroughly but leaves the mechanism-sufficiency causation question underdeveloped — or vice versa — exposes the case to challenge on the unaddressed dimension. The plaintiff expert should address both the diagnostic and causation questions as independent, fully developed analytical tracks in a single opinion.

Deposition and Trial Testimony Considerations

Deposition of a CRPS expert presents challenges specific to the condition's clinical complexity. Defense deposition strategy in CRPS cases typically focuses on three objectives: establishing that the expert cannot identify specific Budapest Criteria sign documentation in the treating record sufficient to meet the criteria; establishing that the expert cannot identify a mechanism in the published literature specifically supporting CRPS onset from the particular type of injury at issue; and establishing that the future care projection rests on assumptions the expert cannot specifically ground in the plaintiff's clinical record.

Preparation for a CRPS deposition should include a systematic review of the Budapest Criteria documentation question — the expert should be able to cite specific treating record entries, by date and clinician, documenting each sign category used to satisfy the criteria. If the record is incomplete in any category, the expert should be prepared to acknowledge that gap honestly and explain what the available record does support, rather than overclaiming completeness. Defense counsel skilled in CRPS deposition will request page-and-line citations for each Budapest Criteria finding; an expert who cannot provide them is vulnerable.

At trial, CRPS expert testimony benefits from a clear, plain-language explanation of the Budapest Criteria structure — juries and judges who understand that the diagnosis requires clinician-observed examination findings, not merely patient-reported symptoms, are better positioned to evaluate the treating record and the competing expert opinions. Visual aids illustrating the four Budapest Criteria categories and the sign/symptom distinction are among the most effective educational tools available in CRPS jury trials.

Questions Attorneys Should Ask

Before retaining a pain management expert for a CRPS case, attorneys should address the following:

• Does the expert have direct, current clinical experience evaluating and treating CRPS patients — not only reviewing CRPS records — including direct physical examination using the Budapest Criteria framework?
• Can the expert identify, for each Budapest Criteria sign category, specific treating record entries documenting examination-level signs — not only patient-reported symptoms?
• Can the expert address the mechanism-sufficiency question with specific citation to published literature on the range of mechanisms documented to precipitate CRPS?
• For cases involving SCS: can the expert evaluate the pre-implant psychological evaluation for adequacy, including the specific instruments used and their appropriateness for CRPS-SCS candidacy?
• For future care opinions: can the expert build the projection component by component, with a specific clinical rationale for each cost category tied to the plaintiff's individual clinical record rather than a generic CRPS template?
• Has the expert addressed CRPS from both the plaintiff and defense side, and can the expert engage the most common defense arguments — mechanism insufficiency, normal imaging, normal EMG, Budapest Criteria documentation gaps — with specific, literature-grounded responses?
• Is the expert available for records review, deposition preparation, deposition, and trial on a timeline consistent with the case schedule?

Conclusion

CRPS is among the most clinically complex and most actively contested diagnoses in pain management litigation — because its diagnosis depends on examination-documented clinical findings that can be recorded well or poorly, because its causation requires addressing a mechanism range that defense experts routinely mischaracterize, and because its future care implications can be substantial enough to drive the overall value of a personal injury or malpractice case. The Budapest Criteria provide a rigorous, internationally validated diagnostic framework, but that framework is only as useful in litigation as the treating record's completeness in documenting examination signs at each required category.

The dual-track analytical requirement — addressing both Budapest Criteria documentation and mechanism-sufficiency causation as independent, fully developed analytical questions — is the defining quality benchmark for a CRPS expert opinion. An expert who addresses both tracks thoroughly, with specific record citation and specific literature grounding for each, provides a substantially more durable opinion than one who conflates the diagnostic and causation questions or who addresses one at the expense of the other. The same discipline — specific, record-grounded, literature-cited reasoning rather than general clinical experience described in the abstract — applies to necessity opinions, future care projections, and standard of care analysis in CRPS malpractice cases.

Dr. Dardashti is available for CRPS expert witness retention for both plaintiff and defense counsel, nationwide. Contact his office at 805-267-9308 to discuss your case.

Related Articles

California Pain Management Expert Witness Guide for Attorneys

Evidence Code §§ 720, 801-802, Sargon, MICRA, comparative fault, QME/AME, and procedure-specific disputes from an actively practicing California pain management physician.

Read article

Texas Chapter 74 and Pain Management Expert Witness Testimony in Personal Injury and Medical Malpractice Cases

Chapter 74 expert report requirements, qualification standards, causation, and procedure-specific disputes including CRPS, SCS, and future medical care for Texas plaintiff and defense counsel.

Read article

How Pain Management Experts Evaluate Causation in Personal Injury Cases

Aggravation doctrine, pre-existing degeneration, CRPS causation disputes, post-laminectomy syndrome chain-of-causation, and the causation foundation required for future care projections.

Read article

How Pain Management Experts Evaluate Medical Necessity in Personal Injury Cases

A clinical framework covering necessity criteria for ESI, MBB/RFA, SCS, IDDS, PNS, and future care projections in personal injury and workers' compensation cases.

Read article

How Pain Management Experts Evaluate Medical Necessity for Spinal Cord Stimulators

SCS trial documentation, permanent implantation criteria, psychological screening, revision disputes, battery replacement projections, and future medical care analysis in litigation.

Read article

Arizona Pain Management Expert Witness Guide

Rule 702, A.R.S. § 12-2604, Rule 26.1, and procedure-specific disputes — including CRPS causation and SCS necessity — for Arizona plaintiff and defense counsel.

Read article

What Is the Difference Between Medical Necessity and Standard of Care?

How to distinguish two clinical concepts that every pain management litigation attorney must understand — with procedure-specific examples across ESI, RFA, SCS, IDDS, and PNS.

Read article